FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Bell

Research Profile

Living Beings

Anatomy

Disorders

Chemicals & Drugs

Co-author Network

Publications

TOP 3
David Bell; Vivienne L S Crawford
"Murder or mercy?" An innovative module helping UK medical students to articulate their own ethical viewpoints regarding end-of-life decisions.
David Bell; Mark Harbinson; Gary Toman; Vivienne L S Crawford; Harold Cunningham
Wholeness of healing: an innovative Student-Selected Component introducing United Kingdom medical students to the spiritual dimension in healthcare.
David Bell; Malcolm Campbell; Xuanhui Wang; J A Philip Earle; S Louise Cosby; Barbara J McDermott
Adrenomedullin gene delivery is cardio-protective in a model of chronic nitric oxide deficiency combining pressure overload, oxidative stress and cardiomyocyte hypertrophy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Bell (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: David Bell; Vivienne L S Crawford
"Murder or mercy?" An innovative module helping UK medical students to articulate their own ethical viewpoints regarding end-of-life decisions.
Southern medical journal 2011;104(10):676-81.
2010: David Bell; Mark Harbinson; Gary Toman; Vivienne L S Crawford; Harold Cunningham
Wholeness of healing: an innovative Student-Selected Component introducing United Kingdom medical students to the spiritual dimension in healthcare.
Southern medical journal 2010;103(12):1204-9.
2010: David Bell; Malcolm Campbell; Xuanhui Wang; J A Philip Earle; S Louise Cosby; Barbara J McDermott
Adrenomedullin gene delivery is cardio-protective in a model of chronic nitric oxide deficiency combining pressure overload, oxidative stress and cardiomyocyte hypertrophy.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2010;26(3):383-94.
2008: David Bell; Youyou Zhao; Francis P G McCoy; Adrian B Devine; Barbara J McDermott
Expression of the counter-regulatory peptide intermedin is augmented in the presence of oxidative stress in hypertrophied cardiomyocytes.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2008;21(5-6):409-20.
2008: David Bell; You You Zhao; Adrian B Devine; Barbara J McDermott
Influence of atenolol and nifedipine on nitric-oxide deficient cardiomyocyte hypertrophy and expression of the cardio-endocrine peptide intermedin and its receptor components.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2008;21(1-3):203-14.
2007: Barbara J McDermott; Stewart McWilliams; Karen Smyth; Elizabeth J Kelso; J Paul Spiers; YouYou Zhao; David Bell; Rajinder K Mirakhur
Protection of cardiomyocyte function by propofol during simulated ischemia is associated with a direct action to reduce pro-oxidant activity.
Journal of molecular and cellular cardiology 2007;42(3):600-8.
2007: David Bell; YouYou Zhao; Francis P G McCoy; Adrian B Devine; Barbara J McDermott
Differential effects of an anti-oxidant intervention on cardiomyocyte expression of adrenomedullin and intermedin and their receptor components in chronic nitric oxide deficiency.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2007;20(5):269-82.
2006: Adrian R Allen; Elizabeth J Kelso; David Bell; Youyou Zhao; Paula Dickson; Barbara J McDermott
Modulation of contractile function through neuropeptide Y receptors during development of cardiomyocyte hypertrophy.
The Journal of pharmacology and experimental therapeutics 2006;319(3):1286-96.
2006: YouYou Zhao; David Bell; Lisa R Smith; Li Zhao; Adrian B Devine; Eugene M McHenry; D Paul Nicholls; Barbara J McDermott
Differential expression of components of the cardiomyocyte adrenomedullin/intermedin receptor system following blood pressure reduction in nitric oxide-deficient hypertension.
The Journal of pharmacology and experimental therapeutics 2006;316(3):1269-81.
2006: David Bell; You-You Zhao; Elizabeth J Kelso; Eugene M McHenry; Louise M Rush; Victoria M Lamont; D Paul Nicholls; Barbara J McDermott
Upregulation of adrenomedullin and its receptor components during cardiomyocyte hypertrophy induced by chronic inhibition of nitric oxide synthesis in rats.
American journal of physiology. Heart and circulatory physiology 2006;290(2):H904-14.
2005: David Bell; Barbara J McDermott
Effects of rosiglitazone and interactions with growth-regulating factors in ventricular cell hypertrophy.
European journal of pharmacology 2005;508(1-3):69-76.
2004: Graham R Lee; David Bell; Elizabeth J Kelso; Cymone C H Argent; Barbara J McDermott
Evidence for altered ETB receptor characteristics during development and progression of ventricular cardiomyocyte hypertrophy.
American journal of physiology. Heart and circulatory physiology 2004;287(1):H425-32.
2004: David Bell; Elizabeth J Kelso; Cymone C H Argent; Graham R Lee; Adrian R Allen; Barbara J McDermott
Temporal characteristics of cardiomyocyte hypertrophy in the spontaneously hypertensive rat.
Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology 2004;13(2):71-8.
2003: Eamonn Bradley; Andrea Law; David Bell; Christopher D Johnson
Effects of varying impulse number on cotransmitter contributions to sympathetic vasoconstriction in rat tail artery.
American journal of physiology. Heart and circulatory physiology 2003;284(6):H2007-14.
2002: David Bell; Adrian R Allen; Elizabeth J Kelso; Ambikaipakan Balasubramaniam; Barbara J McDermott
Induction of hypertrophic responsiveness of cardiomyocytes to neuropeptide Y in response to pressure overload.
The Journal of pharmacology and experimental therapeutics 2002;303(2):581-91.
2002: Suzanne M Nicholl; David Bell; J Paul Spiers; Barbara J McDermott
Neuropeptide Y Y(1) receptor regulates protein turnover and constitutive gene expression in hypertrophying cardiomyocytes.
European journal of pharmacology 2002;441(1-2):23-34.
2001: John Cullen; David Bell; Elizabeth J Kelso; Barbara J McDermott
Use of A-192621 to provide evidence for involvement of endothelin ET(B)-receptors in endothelin-1-mediated cardiomyocyte hypertrophy.
European journal of pharmacology 2001;417(3):157-68.
2001: F Murray; David Bell; Elizabeth J Kelso; B C Millar; Barbara J McDermott
Positive and negative contractile effects of somatostatin-14 on rat ventricular cardiomyocytes.
Journal of cardiovascular pharmacology 2001;37(3):324-32.
2000: David Bell; Barbara J McDermott
Troglitazone does not initiate hypertrophy but can sensitise cardiomyocytes to growth effects of serum.
European journal of pharmacology 2000;390(3):237-44.
1998: David Bell; Barbara J McDermott
D-myo inositol 1,2,6, triphosphate (alpha-trinositol, pp56): selective antagonist at neuropeptide Y (NPY) Y-receptors or selective inhibitor of phosphatidylinositol cell signaling?
General pharmacology 1998;31(5):689-96.
1997: D M Mullan; David Bell; Elizabeth J Kelso; Barbara J McDermott
Involvement of endothelin (ET)A and ETB receptors in the hypertrophic effects of ET-1 in rabbit ventricular cardiomyocytes.
Journal of cardiovascular pharmacology 1997;29(3):350-9.